Simotinib (SIM6802) is a novel orally bioavailable EGFR-epidermal growth factor receptor tyrosine kinase inhibitor with potential anticancer activity. Simotinib has demonstrated equal or superior antineoplastic activities to erlotinib in preclinical studies.

纯度：≥98%

CAS：944258-89-3